合成路线1
该中间体在本合成路线中的序号:
(I) The reaction of 2,6-dimethylaniline (I) with phosgene (II) in refluxing benzene gives 2,6-dimethylphenyl isocyanate (III), which is then condensed with methylguanidine carbonate (A) by means of K2CO3 in THF and treated with HCl to obtain the corresponding hydrochloride.
【1】
Nouvelles amidinourees, leur preparation et leur emploi. BE 0844832 .
|
【2】
Roberts, P.J.; Castaner, J.; Lidamidine hydrochloride. Drugs Fut 1979, 4, 3, 206.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
28411 |
N-Methylguanidine
|
598-12-9 |
C2H7N3 |
详情 | 详情
|
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
29955 |
2,6-Dimethylphenyl isocyanate; 2-Isocyanato-1,3-dimethylbenzene
|
28556-81-2 |
C9H9NO |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) By condensation of 2,6-dimethylaniline (I) with 8-pyrrolizineacetlc acid (II) by means of NaH in refluxing dioxane.
【1】
Miyano, S.; Sumoto, K.; Morita, M.; Sato, F. (Suntory Ltd.); 8-(Substituted-N-phenylcarboxamidomethyl)pyrrolizidines and use thereof as antiarrhythmics. EP 0089061; JP 58159793; US 4564624 .
|
【2】
Thorpe, P.J.; Serradell, M.N.; Castaner, J.; SUN-1165. Drugs Fut 1985, 10, 6, 483.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
29708 |
2-tetrahydro-1H-pyrrolizin-7(5H)-ylacetic acid
|
|
C9H15NO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(III) The synthesis of EO 122 starts from quinuclidine-3-carboxylic acid (I), which is converted to the acid chloride (II) by oxalyl chloride. The addition of 2,6-dimethylaniline (III) to the acid chloride yields EO-122.
【1】
Kaplinsky, E.; Bruckstein, R.; Kariv, E.; Oppenheimer, E.; Cohen, S.; A preclinical study of EO-122, a new lidocaine-lik. Angiology 1980, 31, 410.
|
【2】
Renk, E.; Grob, C.A.; Studie in the quinudidine line. 3-Quinudialine-car. Helv Chim Acta 1954, 37, 1689.
|
【3】
Oppenheimer, E.; Binah, O.; EO-122. Drugs Fut 1988, 13, 8, 724.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
29841 |
Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride
|
79-37-8 |
C2Cl2O2 |
详情 | 详情
|
(I) |
20290 |
3-quinuclidinecarboxylic acid
|
|
C8H13NO2 |
详情 |
详情
|
(II) |
20291 |
3-quinuclidinecarbonyl chloride
|
|
C8H12ClNO |
详情 |
详情
|
(III) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) Compound can be prepared in two different ways both starting from 2,6-xylidine (I):
1) By condensation of (I) with N-carbobenzoxyalanine (B) by means of dicyclohexylcarbodiimide in methylenechloride giving N-(carbobenzoxyalanyl)xylidine (II), which is then hydrogenated over Pd/C in ethanol - methylene chloride.
2) By condensation of (I) with 2-bromopropionyl bromide (A) by means of sodium acetate in acetic acid giving 2-bromo-2',6'-propionoxylidide (III), which is then treated with NH3 in alcohol water.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
13127 |
2-Bromopropionyl bromide; 2-Bromopropanoyl bromide
|
563-76-8 |
C3H4Br2O |
详情 | 详情
|
(B) |
61217 |
CBZ-DL-Alanine; 2-[[(Benzyloxy)carbonyl]amino]propionic acid; N-((Phenylmethoxy)carbonyl)-DL-alanine; Carbobenzyloxy-DL-alanine
|
4132-86-9 |
C11H13NO4 |
详情 | 详情
|
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
33595 |
benzyl 2-(2,6-dimethylanilino)-1-methyl-2-oxoethylcarbamate
|
|
C19H22N2O3 |
详情 |
详情
|
(III) |
33594 |
2-bromo-N-(2,6-dimethylphenyl)propanamide
|
|
C11H14BrNO |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) 1) The acylation of 2,6-dimethylaniline (II) with chloroacetyl chloride by means of triethylamine in dichloromethane gives N-(2,6-dimethylphenyl) chloroacetamide (III), which is condensed with piperidine (IV) in refluxing ethanol to yield N-(2,6-dimethylphenyl)-2-piperazinoacetamide IV). Finally, this compound is condensed with 3-(2-methoxyphenoxy)-12-epoxypropane (VI) in refluxing methanol toluene.
【1】
Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 .
|
【2】
Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) 2) The condensation of epoxide (VI) with piperazine (IV) in refluxing isopropanol gives 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]piperazine (VII), which is then condensed with chloroacetamide (III) in refluxing ethanol.
【1】
Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 .
|
【2】
Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(VII) |
24109 |
1-(2-methoxyphenoxy)-3-(1-piperazinyl)-2-propanol
|
|
C14H22N2O3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VII) The hydrolysis of 1-benzyl-4-(methylamino)piperidine-4-carboxamide (I) with refluxing concentrated aqueous HCl gives the corresponding free acid (II), which is debenzylated with H2 over Pd/C in basic medium yielding 4-(methylamino)piperidine-4-carboxylic acid sodium salt (III). The protection of (III) with benzyl chloroformate (IV) in basic THF - water affords 1-(benzyloxycarbonyl)-4-(methylamino)piperidine 4 carboxylic acid (V), which by cyclization with phosgene in dioxane is converted to benzyl 1-methyl-2,4-dioxo 3-oxa-1,8-diazaspiro[4.5]decane-8 carboxylate (VI). The reaction of (VI) with 2,6-dimethylaniline (II) by heating at 160 C gives benzyl 4-(2,6-dimethylphenylaminocarbonyl)-4-(methylamino)piperidine-1-carboxylate (VIII), which is methylated with refluxing methyl iodide to the corresponding dimethylamino compound (IX). The deprotection of (IX) with H2 over Pd/C in methanol yields 4-(dimethylamino)-N-(2,6-dimethylphenyl)piperidine-4-carboxamide (X), which is finally condensed with 1,2-epoxycyclohexane (XI) in refluxing ethanol.
【1】
De Bruyn, M.F.L.; Van Daele, G.H.P.; Verdonck, M.G.C. (Janssen Pharmaceutica NV); N-Aryl-alpha-aminocarboxamide derivs.. EP 0121972; ES 8506615 .
|
【2】
Castaner, J.; Prous, J.; Transcainidine. Drugs Fut 1988, 13, 3, 239.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22019 |
1-benzyl-4-(methylamino)-4-piperidinecarboxamide
|
1024-11-9 |
C14H21N3O |
详情 | 详情
|
(II) |
22020 |
1-benzyl-4-(methylamino)-4-piperidinecarboxylic acid
|
|
C14H20N2O2 |
详情 |
详情
|
(III) |
22021 |
sodium 4-(methylamino)-4-piperidinecarboxylate
|
|
C7H13N2NaO2 |
详情 |
详情
|
(IV) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(V) |
22023 |
1-[(benzyloxy)carbonyl]-4-(methylamino)-4-piperidinecarboxylic acid
|
|
C15H20N2O4 |
详情 |
详情
|
(VI) |
22024 |
benzyl 1-methyl-2,4-dioxo-3-oxa-1,8-diazaspiro[4.5]decane-8-carboxylate
|
|
C16H18N2O5 |
详情 |
详情
|
(VII) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(VIII) |
22026 |
benzyl 4-[(2,6-dimethylanilino)carbonyl]-4-(methylamino)-1-piperidinecarboxylate
|
|
C23H29N3O3 |
详情 |
详情
|
(IX) |
22027 |
benzyl 4-(dimethylamino)-4-[(2,6-dimethylanilino)carbonyl]-1-piperidinecarboxylate
|
|
C24H31N3O3 |
详情 |
详情
|
(X) |
22028 |
4-(dimethylamino)-N-(2,6-dimethylphenyl)-4-piperidinecarboxamide
|
|
C16H25N3O |
详情 |
详情
|
(XI) |
17986 |
7-oxabicyclo[4.1.0]heptane; cyclohexene oxide
|
286-20-4 |
C6H10O |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) By condensation of 2-(2-oxopyrrolidino)acetic acid (I) with 2,6-dimethylaniline (II) by means of dicyclohexylcarbodiimide (DCC) in refluxing chloroform.
【1】
Betzing, H.; Biedermann, J.; Materne, C.; Neuser, V. (A. Nattermann & Cie. GmbH); Pyrrolidin-2-on-1-ylacetic acid 2,6-dimethylanilide, process of preparation and pharmaceutical compsns. containing them. DE 2924011 .
|
【2】
Prous, J.; Castaner, J.; DM-9384. Drugs Fut 1989, 14, 1, 17.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19556 |
2-(2-oxo-1-pyrrolidinyl)acetic acid
|
|
C6H9NO3 |
详情 |
详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) 4-Nitrobenzoylchloride (I) is condensed with 2,6-dimethylaniline (II) in the presence of base (potassium carbonate or triethylamine) to provide the 4-nitrobenzamide (III). Reduction of the aromatic nitro group in (III) using catalytic hydrogenation produces the corresponding 4-aminobenzamide, ameltolide.
【1】
Clark, C.R.; Robertson, D.W.; Leander, J.D.; AMELTOLIDE. Drugs Fut 1990, 15, 10, 983.
|
【2】
Clark, C.R.; Sansom, R.T.; Lin, C.-M.; Norris, G.N.; Anticonvulsant activity of some 4-aminobenzanilides. J Med Chem 1985, 28, 9, 1259.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
31178 |
N-(2,6-dimethylphenyl)-4-nitrobenzamide
|
|
C15H14N2O3 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) Optical resolution of DL-pipecolinic acid (I) with (+)-tartaric acid gives L-pipecolinic acid (II), which is treated with PCl5 to obtain acil chloride (III). This compound is condensed with 2,5-dimethylaniline (IV) by means N-methylpirrolidine (NMP) to afford amide (V). Finally, amide (V) is alkylated with 1-bromopropane by means potassium carbonate (K2CO3) to yield Ropivacaine.
【1】
Sandeberg, R.V. (AstraZeneca plc); S-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it. EP 0239710; US 4870086 .
|
【2】
T. af Ekenstam, B.; Bovin, C. (Alpharma Inc.); L-N-n-Propylpipecolic acid-2,6-xylidide and method for preparing the same. JP 1985502054; WO 8500599 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17532 |
2-piperidinecarboxylic acid; pipecolic acid
|
535-75-1 |
C6H11NO2 |
详情 | 详情
|
(II) |
17380 |
(2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid
|
3105-95-1 |
C6H11NO2 |
详情 | 详情
|
(III) |
19499 |
(2S)-2-piperidinecarbonyl chloride
|
|
C6H10ClNO |
详情 |
详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
17531 |
(2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(VI) |
19502 |
Propyl bromide; 1-Bromopropane
|
106-94-5 |
C3H7Br |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV) Compound (XII) is protected with benzyl chloroformiate (VII) to afford compound (XIII), which is condensed with 2,5-dimethylaniline (XIV) by means SOCl2/DMAP to yield amide (XIV). This compound (XIV) is deprotected by means trimethylsillyl chloride to yield compound (XV), which is hydrogenated by means Rh/Al2O3. Finally, this compound (V) is alkylated with 1-iodopropane by means potassium carbonate (K2CO3) to yield Ropivacaine.
【1】
T. af Ekenstam, B.; Bovin, C. (Alpharma Inc.); L-N-n-Propylpipecolic acid-2,6-xylidide and method for preparing the same. JP 1985502054; WO 8500599 .
|
【2】
Sandeberg, R.V. (AstraZeneca plc); S-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it. EP 0239710; US 4870086 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
28758 |
1-iodopropane
|
107-08-4 |
C3H7I |
详情 | 详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
17531 |
(2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(VII) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(XII) |
19508 |
(2S)-1,2,3,4-tetrahydro-2-pyridinecarboxylic acid
|
|
C6H9NO2 |
详情 |
详情
|
(XIII) |
19509 |
(2S)-1-[(benzyloxy)carbonyl]-1,2,3,4-tetrahydro-2-pyridinecarboxylic acid
|
|
C14H15NO4 |
详情 |
详情
|
(XIV) |
19510 |
benzyl (2S)-2-[(2,6-dimethylanilino)carbonyl]-3,4-dihydro-1(2H)-pyridinecarboxylate
|
|
C22H24N2O3 |
详情 |
详情
|
(XV) |
19511 |
(2S)-N-(2,6-dimethylphenyl)-1,2,3,4-tetrahydro-2-pyridinecarboxamide
|
|
C14H18N2O |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(IV) 1) The optical resolution of pipecolic acid (I) with (+)-tartaric acid in water-ethanol gives L-pipecolic acid (II), which by reaction with Cl5P in acetyl chloride is converted to the acyl chloride (III). The condensation of (III) with 2,6-xylidine (IV) by means of N-methylpyrrolidone (NMP) in acetone affords L-pipecolic acid 2,6-xylidide (V), which is finally alkylated with propyl bromide (VI) and K2CO3 in hot isopropanol.
【1】
T. af Ekenstam, B.; Bovin, C. (Astra Lakemedel AB); L-N-n-Propylpipecolic acid 2,6-xylidide. US 4695576 .
|
【2】
Prous, J.; Castaner, J.; ROPIVACAINE HYDROCHLORIDE < Rec INNM >. Drugs Fut 1989, 14, 8, 767.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17532 |
2-piperidinecarboxylic acid; pipecolic acid
|
535-75-1 |
C6H11NO2 |
详情 | 详情
|
(II) |
17380 |
(2S)hexahydro-2-pyridinecarboxylic acid; (S)-pipecolic acid
|
3105-95-1 |
C6H11NO2 |
详情 | 详情
|
(III) |
19499 |
(2S)-2-piperidinecarbonyl chloride
|
|
C6H10ClNO |
详情 |
详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
17531 |
(2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(VI) |
19502 |
Propyl bromide; 1-Bromopropane
|
106-94-5 |
C3H7Br |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) 3) The protection of 1,2,3,6-tetrahydropyridine-2(S)-carboxylic acid (XII) with benzyl chloroformate (VII) gives the benzyloxycarbonyl derivative (XIII), which is condensed with 2,6-xylidine (IV) with SOCl2 and DMAP as before yielding the amide (XIV). Deprotection of (XIV) with iodotrimethylsilane in dichloromethane affords N-(2,6-dimethylphenyl)-1,2,3,6-tetrahydropyridine-2(S)-carboxamide (XV), which is reduced with H2 over Rh/Al2O3 in DMF giving the saturated amide (V). Finally, this compound is alkylated with propyl iodide and K2CO3 as before.
【1】
Prous, J.; Castaner, J.; ROPIVACAINE HYDROCHLORIDE < Rec INNM >. Drugs Fut 1989, 14, 8, 767.
|
【2】
Gawell, L.; Synthesis of tritium labelled ropivacaine - A new potential local anaesthetic. J Label Compd Radiopharm 1987, 24, 5, 521.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
17531 |
(2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(VI) |
19502 |
Propyl bromide; 1-Bromopropane
|
106-94-5 |
C3H7Br |
详情 | 详情
|
(VII) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(XII) |
19508 |
(2S)-1,2,3,4-tetrahydro-2-pyridinecarboxylic acid
|
|
C6H9NO2 |
详情 |
详情
|
(XIII) |
19509 |
(2S)-1-[(benzyloxy)carbonyl]-1,2,3,4-tetrahydro-2-pyridinecarboxylic acid
|
|
C14H15NO4 |
详情 |
详情
|
(XIV) |
19510 |
benzyl (2S)-2-[(2,6-dimethylanilino)carbonyl]-3,4-dihydro-1(2H)-pyridinecarboxylate
|
|
C22H24N2O3 |
详情 |
详情
|
(XV) |
19511 |
(2S)-N-(2,6-dimethylphenyl)-1,2,3,4-tetrahydro-2-pyridinecarboxamide
|
|
C14H18N2O |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) Phthalimide (III) was prepared by condensation of 4-nitrophthalic anhydride (I) with 2,6-dimethylaniline (II) in refluxing AcOH. Reduction of the nitro group of (II) by transfer hydrogenation using cyclohexene and Pd/C provided the title aminophthalimide.
【1】
Vamecq, J.; Lambert, D.; Poupaert, J.H.; Masereel, B.; Stables, J.P.; Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide. J Med Chem 1998, 41, 18, 3307.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31028 |
5-nitro-2-benzofuran-1,3-dione
|
5466-84-2 |
C8H3NO5 |
详情 | 详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
34935 |
2-(2,6-dimethylphenyl)-5-nitro-1H-isoindole-1,3(2H)-dione
|
|
C16H12N2O4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(III) Levobupivacaine has been obtained by two different ways:
1) The deamination of N-benzoyloxycarbonyl-L-lysine (I) with NaNO2/acetic acid gives 6-acetoxy-2(S)-(benzyl-oxycarbonylamino)hexanoic acid (II), which is amidated with 2,6-dimethylaniline (III) and dicyclohexylcarbodiimide (DCC) to the expected amide (IV). The deacetylation of (IV) with K2CO3 in methanol affords compound (V), which is tosylated as usual with tosyl chloride giving intermediate (VI), which is stereospecifically cyclized by means of K2CO3 in ethanol yielding N-(2,6-dimethyl-phenyl)piperidine-2 (S)-carboxamide (VII). Finally, this compound is alkylated with butyl bromide and K2CO3 or by reductoalkylation with butyraldehyde.
2) The amidation of piperidine-2-carboxylic acid (VIII) with 2,6-dimethylaniline (III) by means of SOCl2 in toluene gives the corresponding amide (IX), which is alkylated with butyl bromide as before yielding racemic bupivacaine (X) (3). This compound is then submitted to optical resolution by treatment with (S,S)-()-tartaric acid followed by crystallization of the resulting tartrate and acidification with HCl in isopropanol.
【1】
Dyer, U.; Hutton, G.; Adger, B.; Woods, M.; Stereospecific synthesis of the anaesthetic levobupivacaine. Tetrahedron Lett 1996, 37, 35, 6399-402.
|
【2】
Skead, B.M.; Langston, M. (Celltech Chiroscience plc); Crystallization of levobupicavaine and analogues thereof. WO 9612699 .
|
【3】
Hutton, G.E. (Celltech Chiroscience plc); The manufacture of levo-bupivacaine and analogues thereof from L-lysine. WO 9611181 .
|
【4】
Frampton, G.A.C.; Zavareh, H.S. (Celltech Chiroscience plc); Progress for preparing levobupivacaine and analogues thereof. WO 9612700 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17525 |
(2S)-6-amino-2-[[(benzyloxy)carbonyl]amino]hexanoic acid
|
|
C14H20N2O4 |
详情 |
详情
|
(II) |
17526 |
(2S)-6-(acetoxy)-2-[[(benzyloxy)carbonyl]amino]hexanoic acid
|
|
C16H21NO6 |
详情 |
详情
|
(III) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(IV) |
17528 |
(5S)-5-[[(benzyloxy)carbonyl]amino]-6-(2,6-dimethylanilino)-6-oxohexyl acetate
|
|
C24H30N2O5 |
详情 |
详情
|
(V) |
17529 |
benzyl (1S)-1-[(2,6-dimethylanilino)carbonyl]-5-hydroxypentylcarbamate
|
|
C22H28N2O4 |
详情 |
详情
|
(VI) |
17530 |
(5S)-5-[[(benzyloxy)carbonyl]amino]-6-(2,6-dimethylanilino)-6-oxohexyl 4-methylbenzenesulfonate
|
|
C29H34N2O6S |
详情 |
详情
|
(VII) |
17531 |
(2S)-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(VIII) |
17532 |
2-piperidinecarboxylic acid; pipecolic acid
|
535-75-1 |
C6H11NO2 |
详情 | 详情
|
(IX) |
17533 |
N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
(X) |
17534 |
1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
2180-92-9 |
C18H28N2O |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(I) Compound can be prepared in two related ways:
1) The acylation of 2,6-dimethylaniline (I) with chloroacetyl chloride (II) in acetic acid gives omega-chloro-2,6-dimethylacetanilide (III), which is then condensed with disodium salt of iminodiacetic acid (IV) in refluxing ethanol-water.
2) The reaction of (III) with ammonia in ethanol gives omega-amino-2,6-dimethylacetanilide (V), which is finally treated with chloroacetic acid (A) and NaOH in refluxing 95% ethanol.
【1】
Castaner, J.; Blancafort, P.; Serradell, M.N.; Paton, D.M.; Lidofenin. Drugs Fut 1979, 4, 5, 342.
|
【2】
Callery, P.S.; et al.; Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid. J Med Chem 1976, 19, 7, 962-964.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(III) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(IV) |
39492 |
2-[(carboxymethyl)amino]acetic acid
|
142-73-4 |
C4H7NO4 |
详情 | 详情
|
(V) |
39493 |
2-amino-N-(2,6-dimethylphenyl)acetamide
|
|
C10H14N2O |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) A pyridine carboxylic acid anilide (III) can be produced by reacting a pyridine carboxylic acid chloride (I) with an aromatic amine (II). The pyridine carboxylic acid anilide (III) is hydrogenated to the corresponding piperidine carboxylic acid anilide (IV), which is thereafter hydroalkylated
【1】
Aberg, G.; Droxicainide. Drugs Fut 1983, 8, 6, 492.
|
【2】
af Ekenstam, B.; Aberg, A.K.G.; US 4302465 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29205 |
2-pyridinecarbonyl chloride
|
|
C6H4ClNO |
详情 |
详情
|
(II) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(III) |
61079 |
N-(2,6-dimethylphenyl)-2-pyridinecarboxamide
|
|
C14H14N2O |
详情 |
详情
|
(IV) |
17533 |
N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
|
|
C14H20N2O |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(IV)
【1】
Li SC, Huang HQ, Li ZJ. 2003. Synthesis of a novel antianginal agent Ranolazine. 中国药物化学杂志,13: 283~285 |
【2】
Lu WC, Li YQ, Zhao XG, et aL. 2004. Synthesis of ranolazine中国医药工业杂志,35: 641~642 |
【3】
Wang LS, Feng XY, Zhu HY. 2003. Synthesis of anti-angina drug ranolazine. 广西大学学报,自然科学版,28: 301~303 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|
(IV) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(V) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(VI) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(I)
【1】
Yan J.2007. Synthesis of ranolazine.中国专利申请公开说明书.CN 1915982 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17527 |
2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine
|
87-62-7 |
C8H11N |
详情 | 详情
|
(II) |
24100 |
2-chloro-N-(2,6-dimethylphenyl)acetamide
|
2198-53-0 |
C10H12ClNO |
详情 | 详情
|
(III) |
24102 |
N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide
|
|
C14H21N3O |
详情 |
详情
|
(IV) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(VI) |
24103 |
2-[(2-methoxyphenoxy)methyl]oxirane
|
|
C10H12O3 |
详情 |
详情
|